Literature DB >> 4342703

Pancreatic islet beta cell tumors and hyperplasia: experience in 14 Seattle hospitals.

H Kavlie, T T White.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4342703      PMCID: PMC1355177          DOI: 10.1097/00000658-197203000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  17 in total

1.  PLASMA INSULIN IN ORGANIC HYPERINSULINISM: COMPARATIVE EFFECTS OF TOLBUTAMIDE, LEUCINE AND GLUCOSE.

Authors:  J C FLOYD; S S FAJANS; R F KNOPF; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1964-08       Impact factor: 5.958

2.  ANGIOGRAPHIC DIAGNOSIS OF AN ISLET CELL TUMOR OF THE PANCREAS.

Authors:  O OLSSON
Journal:  Acta Chir Scand       Date:  1963-10

3.  FUNCTIONING ADENOMAS OF PANCREAS WITH HYPERINSULINISM: REPORT OF 13 PATIENTS.

Authors:  D R MILLER
Journal:  Arch Surg       Date:  1965-04

4.  "BLIND" DISTAL PANCREATECTOMY.

Authors:  D R MILLER
Journal:  Surg Gynecol Obstet       Date:  1965-09

5.  The diagnostic value of sodium tolbutamide in hypoglycemic states.

Authors:  S S FAJANS; J M SCHNEIDER; D E SCHTEINGART; J W CONN
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

6.  Studies on patients with islet-cell tumor, including the phenomenon of leucine-induced accentuation of hypoglycemia.

Authors:  G C FLANAGAN; T B SCHWARTZ; W G RYAN
Journal:  J Clin Endocrinol Metab       Date:  1961-04       Impact factor: 5.958

7.  Clinics on endocrine and metabolic diseases. 3. Hyperinsulinism: review of 95 cases of functioning pancreatic islet cell tumors.

Authors:  D A SCHOLZ; W H REMINE; J T PRIESTLEY
Journal:  Proc Staff Meet Mayo Clin       Date:  1960-09-14

8.  Planning the appropriate operations for islet cell tumors of the pancreas.

Authors:  F A DePeyster
Journal:  Surg Clin North Am       Date:  1970-02       Impact factor: 2.741

9.  Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin.

Authors:  I M Murray-Lyon; A L Eddleston; R Williams; M Brown; B M Hogbin; A Bennett; J C Edwards; K W Taylor
Journal:  Lancet       Date:  1968-10-26       Impact factor: 79.321

10.  Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects.

Authors:  S A BERSON; R S YALOW; A BAUMAN; M A ROTHSCHILD; K NEWERLY
Journal:  J Clin Invest       Date:  1956-02       Impact factor: 14.808

View more
  8 in total

1.  Insulinoma complicating tuberous sclerosis.

Authors:  P M Davoren; M T Epstein
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

2.  An insulinoma presenting with reactive hypoglycaemia.

Authors:  H Connor; J H Scarpello
Journal:  Postgrad Med J       Date:  1979-10       Impact factor: 2.401

3.  Localization of occult insulin secreting tumors of the pancreas.

Authors:  H Kallio; H Suoranta
Journal:  Ann Surg       Date:  1979-01       Impact factor: 12.969

4.  Current surgical management of functioning islet cell tumors of the pancreas.

Authors:  T S Harrison; C G Child; W J Fry; J C Floyd; S S Fajans
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

5.  Pancreatic islet beta cell tumours.

Authors:  I D Johnston
Journal:  Proc R Soc Med       Date:  1972-10

6.  Insulinoma: clinical manifestations, diagnosis and treatment. The significance of the prolonged fasting test and of the fasting blood glucose-insulin relationship.

Authors:  K Johansen
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 7.  Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.

Authors:  Thorvardur R Halfdanarson; Joseph Rubin; Michael B Farnell; Clive S Grant; Gloria M Petersen
Journal:  Endocr Relat Cancer       Date:  2008-06       Impact factor: 5.678

8.  Hypoglycemia and insular hyperplasia: review of 148 cases.

Authors:  P Stefanini; M Carboni; N Patrassi; A Basoli
Journal:  Ann Surg       Date:  1974-07       Impact factor: 12.969

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.